ArticleFrontiers in nuclear medicine2022

DOTA Conjugate of Bisphosphonate and PSMA-Inhibitor: A Promising Combination for Therapy of Prostate Cancer Related Bone Metastases.

Tilmann Grus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.